LUIS RAMOS: Open Payments
NPI 1437801586 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$616 in 29 payments from 12 companies in 2025. Trend: 2023 $1,253 · 2024 $1,835 · 2025 $616
Food & beverage: $616
| Company | Payments | Amount |
|---|---|---|
| Bausch Health US, LLC | 5 | $127 |
| Axsome Therapeutics, Inc. | 4 | $109 |
| Otsuka America Pharmaceutical, Inc. | 5 | $79 |
| Corium, LLC | 3 | $66 |
| Collegium Pharmaceutical, Inc. | 3 | $46 |
| Alkermes, Inc. | 2 | $43 |
| Janssen Pharmaceuticals, Inc | 1 | $38 |
| Supernus Pharmaceuticals, Inc. | 2 | $34 |
| Vertical Pharmaceuticals, LLC | 1 | $22 |
| Neurocrine BioSciences, Inc. | 1 | $22 |
Products named: APLENZIN, Auvelity, REXULTI, Azstarys, Jornay PM, LYBALVI, INVEGA SUSTENNA, Qelbree.
Industry payments across TX — which companies pay providers there.
